Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins

Molecular Aspects of Medicine

Volumn 31, Issue 5, 2010, Pages 333-343

  Van Prooyen, Nancy ^a   Andresen, Vibeke ^a   Gold, Heather ^a   Bialuk, Izabela ^a   Pise Masison, Cynthia ^a   Franchini, Genoveffa ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HTLV 1; Immunological synapse; Orf I; P12; P8; T cells; Virus transmission

Indexed keywords

CALCIUM; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEIN P12; PROTEIN P8; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CALCIUM TRANSPORT; CELL CONTACT; CELLULAR DISTRIBUTION; CLONAL ANERGY; CYTOKINE PRODUCTION; ENDOPLASMIC RETICULUM; GENETIC POLYMORPHISM; GOLGI COMPLEX; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; OPEN READING FRAME; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS GENE; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

CELL COMMUNICATION; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; OPEN READING FRAMES; T-LYMPHOCYTES; VIRAL PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

HUMAN T-LYMPHOTROPIC VIRUS 1; MACACA;

EID: 77958486870     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2010.07.001     Document Type: Review

References (90)

1. Albrecht B., D'Souza C.D., Ding W., Tridandapani S., Coggeshall K.M., Lairmore M.D. Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I). J. Virol. 2002, 76:3493-3501.
2. Allan J.S., Leland M., Broussard S., Mone J., Hubbard G. Simian T-cell lymphotropic viruses (STLVs) and lymphomas in African nonhuman primates. Cancer Invest 2001, 19:383-395.
3. Andresen, V., Pise-Masison, C., Sinha-Datta, U., Parks, R.W., Cecchinato, V., Fukumoto, R., Nicot, C., Franchini, G., submitted for publication. Suppression of HLV-I Replication by Tax-mediated Re-routing of the p13 Viral Protein to Nuclear Speckles.
4. Arnold J., Yamamoto B., Li M., Phipps A.J., Younis I., Lairmore M.D., Green P.L. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 2006, 107:3976-3982.
5. Banerjee P., Feuer G., Barker E. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. J. Virol. 2007, 81:9707-9717.
6. Baydoun H.H., Bellon M., Nicot C. HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking. AIDS Rev. 2008, 10:195-204.
7. Beby-Defaux A., Frugier F., Bourgoin A., Moynet D., Hajjar C., Sainte-Foie S., Guillemain B., Agius G. Nucleotide sequence analysis of human T-cell lymphotropic virus type I pX and LTR regions from patients with sicca syndrome. J. Med. Virol. 1999, 59:245-255.
8. Beilke M.A., Traina-Dorge V., England J.D., Blanchard J.L. Polymyositis, arthritis, and uveitis in a macaque experimentally infected with human T lymphotropic virus type I. Arthritis Rheum. 1996, 39:610-615.
9. Berneman Z.N., Gartenhaus R.B., Reitz M.S., Blattner W.A., Manns A., Hanchard B., Ikehara O., Gallo R.C., Klotman M.K. Expression of alternatively spliced human T-lymphotropic virus type I (HTLV-I) pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc. Natl. Acad. Sci. USA 1992, 89:3005-3009.
10. Bunn P.A., Schechter G.P., Jaffe E., Blayney D., Young R.C., Matthews M.J., Blattner W., Broder S., Robert-Guroff M., Gallo R.C. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N. Engl. J. Med. 1983, 309:257-264.
11. Cereseto A., Berneman Z., Koralnik I., Vaughn J., Franchini G., Klotman M.E. Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines. Leukemia 1997, 11:866-870.
12. Chow A.Y., Mellman I. Old lysosomes, new tricks: MHC II dynamics in DCs. Trends Immunol. 2005, 26:72-78.
13. Ciminale V., D'Agostino D.M., Zotti L., Franchini G., Felber B.K., Chieco-Bianchi L. Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology 1995, 209:445-456.
14. Ciminale V., Pavlakis G.N., Derse D., Cunningham C.P., Felber B.K. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV-I. J. Virol. 1992, 66:1737-1745.
15. Ciminale V., Zotti L., D'Agostino D.M., Ferro T., Casareto L., Franchini G., Bernardi P., Chieco-Bianchi L. Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). Oncogene 1999, 18:4505-4514.
16. I reduces viral infectivity in vivo. Blood 1998, 91:4701-4707.
17. Dekaban G.A., Peters A.A., Mulloy J.C., Johnson J.M., Trovato R., Rivadeneira E., Franchini G. The HTLV-I orf I protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits. Virology 2000, 274:86-93.
18. Derse D., Mikovits J., Ruscetti F. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 1997, 237:123-128.
19. Ding W., Albrecht B., Kelley R.E., Muthusamy N., Kim S.J., Altschuld R.A., Lairmore M.D. Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J. Virol. 2002, 76:10374-10382.
20. Ding W., Albrecht B., Luo R., Zhang W., Stanley J.R., Newbound G.C., Lairmore M.D. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J. Virol. 2001, 75:7672-7682.
21. Ding W., Kim S.J., Nair A.M., Michael B., Boris-Lawrie K., Tripp A., Feuer G., Lairmore M.D. Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation. J. Virol. 2003, 77:11027-11039.
22. Fitzgerald K.A., Golenbock D.T. Immunology. The shape of things to come. Science 2007, 316:1574-1576.
23. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 1995, 86:3619-3639.
24. Franchini, G., Lairmore, M.D., 2007. Human T-cell leukemia/lymphoma virus types 1 and 2. in: L.W. &.W. (Ed.), Fields virology. Philadelphia, pp. 2071-2106.
25. I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. J. Virol. 1993, 67:7701-7704.
26. Fukumoto R., Andresen V., Bialuk I., Cecchinato V., Walser J.C., Valeri V.W., Nauroth J.M., Gessain A., Nicot C., Franchini G. In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. Blood 2009, 113:3726-3734.
27. Fukumoto R., Dundr M., Nicot C., Adams A., Valeri V.W., Samelson L.E., Franchini G. Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12I protein of human T-cell leukemia/lymphoma virus type 1. J. Virol. 2007, 81:9088-9099.
28. Furukawa K., Furukawa K., Shiku H. Alternatively spliced mRNA of the pX region of human T-lymphotropic virus type 1 proviral genome. FEBS Lett. 1991, 295:141-145.
29. Furukawa Y., Usuku K., Izumo S., Osame M. Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo. AIDS Res. Hum. Retroviruses 2004, 20:1092-1099.
30. Gaudray G., Gachon F., Basbous J., Biard-Piechaczyk M., Devaux C., Mesnard J.M. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 2002, 76:12813-12822.
31. Gessain A. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection. J. Neurovirol. 1996, 2:299-306.
32. Hajjar C., Sainte-Foie S., Savin J., Lacave J., Berlet F., Teron-Aboud B., Batelier L., Guillemin B. HTLV1 infection and sicca syndrome. J. Fr. Ophtalmol. 1995, 18:597-602.
33. Igakura T., Stinchcombe J.C., Goon P.K., Taylor G.P., Weber J.N., Griffiths G.M., Tanaka Y., Osame M., Bangham C.R. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003, 299:1713-1716.
34. Iniguez A.M., Otsuki K., Magalhaes G.P., Silva E.A., Vicente A.C. Genetic markers on the HTLV-1 p12I protein sequences from Brazilian HAM/TSP patients and asymptomatic HTLV-1 carrier isolates. AIDS Res. Hum. Retroviruses 2005, 21:580-582.
35. Jacobson S., Shida H., McFarlin D.E., Fauci A.S., Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990, 348:245-248.
36. I protein. J. Virol. 2001, 6086-6094.
37. Johnson J.M., Harrod R., Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int. J. Exp. Pathol. 2001, 82:135-147.
38. Johnson J.M., Mulloy J.C., Ciminale V., Fullen J., Nicot C., Franchini G. The MHC class I heavy chain is a common target of the small proteins encoded by the 3′ end of HTLV type 1 and HTLV type 2. AIDS Res. Hum. Retroviruses 2000, 16:1777-1781.
39. Jones K.S., Petrow-Sadowski C., Huang Y.K., Bertolette D.C., Ruscetti F.W. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat. Med. 2008, 14:429-436.
40. Kannagi M., Matsushita S., Harada S. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells. Int. J. Cancer 1993, 54:582-588.
41. Kannagi M., Matsushita S., Shida H., Harada S. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection. Leukemia 1994, 8(Suppl. 1):S54-S59.
42. Kim S.J., Ding W., Albrecht B., Green P.L., Lairmore M.D. A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation. J. Biol. Chem. 2003, 278:15550-15557.
43. Kim S.J., Nair A.M., Fernandez S., Mathes L., Lairmore M.D. Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. J. Immunol. 2006, 176:5463-5470.
44. Koralnik I., Gessain A., Klotman M.E., Lo Monico A., Berneman Z.N., Franchini G. Protein isoforms encoded by the pX region of the human T-cell leukemia/lymphotropic virus type I. Proc. Natl. Acad. Sci. USA 1992, 89:8813-8817.
45. I and the vacuolar H+ATPase 16kDa subunit protein. J. Gen. Virol. 1995, 76:1909-1916.
46. II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J. Virol. 1993, 67:2360-2366.
47. Lairmore M.D., Silverman L., Ratner L. Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 2005, 24:6005-6015.
48. Li M., Kesic M., Yin H., Yu L., Green P.L. Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals. J. Virol. 2009, 83:3788-3797.
49. Lin H.C., Hickey M., Hsu L., Medina D., Rabson A.B. Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression. Virology 2005, 339:1-11.
50. Majorovits E., Nejmeddine M., Tanaka Y., Taylor G.P., Fuller S.D., Bangham C.R. Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PLoS. One. 2008, 3:e2251.
51. Mann D.L., Popovic M., Sarin P., Murray C., Reitz M.S., Strong D.M., Haynes B.F., Gallo R.C., Blattner W.A. Cell lines producing human T-cell lymphoma virus show altered HLA expression. Nature 1983, 305:58-60.
52. Manz B.N., Groves J.T. Spatial organization and signal transduction at intercellular junctions. Nat. Rev. Mol. Cell Biol. 2010, 11:342-352.
53. Marshansky V., Futai M. The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function. Curr. Opin. Cell Biol. 2008, 20:415-426.
54. Martins M.L., Soares B.C., Ribas J.G., Thorun G.W., Johnson J., Kroon E.G., Carneiro-Prioetti A.B., Bonjardim C.A. Frequency of p12K and p12R alleles of HTLV Type 1 in HAM/TSP patients and in asymptomatic HTLV type 1 carriers. AIDS Res. Hum. Retroviruses 2002, 18:899-902.
55. Matsuoka M., Green P.L. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 2009, 6:71.
56. Michael B., Nair A.M., Hiraragi H., Shen L., Feuer G., Boris-Lawrie K., Lairmore M.D. Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology 2004, 1:39.
57. Migone T.S., Lin J.X., Cereseto A., Mulloy J.C., O'Shea J.J., Franchini G., Leonard W.J. Constitutively activated JAK-STAT pathway in T-cells transformed with HTLV-I. Science 1995, 269:79-81.
58. c chains and affects their expression on the cell surface. J. Virol. 1996, 70:3599-3605.
59. Nakamura H., Eguchi K., Nakamura T., Mizokami A., Shirabe S., Kawakami A., Matsuoka N., Migita K., Kawabe Y., Nagataki S. High prevalence of Sjogren's syndrome in patients with HTLV-I associated myelopathy. Ann. Rheum. Dis. 1997, 56:167-172.
60. Negulescu P.A., Shastri N., Cahalan M.D. Intracellular calcium dependence of gene expression in single T lymphocytes. Proc. Natl. Acad. Sci. USA 1994, 91:2873-2877.
61. Nicot C., Dundr M., Johnson J.M., Fullen J.R., Alonzo N., Fukumoto R., Princler G.L., Derse D., Misteli T., Franchini G. HTLV-1-encoded p30(II) is a post-transcriptional negative regulator of viral replication. Nat. Med. 2004, 10:197-201.
62. Nicot C., Mulloy J.C., Ferrari M.G., Johnson J.M., Fu K., Fukumoto R., Trovato R., Fullen J., Leonard W.J., Franchini G. HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood 2001, 98:823-829.
63. Parker C.E., Daenke S., Nightingale S., Bangham C.R. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992, 188:628-636.
64. Pique C., Ureta-Vidal A., Gessain A., Chancerel B., Gout O., Tamouza R., Agis F., Dokhelar M.C. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J. Exp. Med. 2000, 191:567-572.
65. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980, 77:7415-7419.
66. Poiesz B.J., Ruscetti F.W., Mier J.W., Woods A.M., Gallo R.C. T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. Proc. Natl. Acad. Sci. USA 1980, 77:6815-6819.
67. Robek M.D., Wong F.-H., Ratner L. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J. Virol. 1998, 72:4458-4462.
68. Satou Y., Yasunaga J., Yoshida M., Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. USA 2006, 103:720-725.
69. Silic-Benussi M., Cannizzaro E., Venerando A., Cavallari I., Petronilli V., La R.N., Marin O., Chieco-Bianchi L., Di L.F., D'Agostino D.M., Bernardi P., Ciminale V. Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1. Biochim. Biophys. Acta 2009, 1787:947-954.
70. Silic-Benussi M., Marin O., Biasiotto R., D'Agostino D.M., Ciminale V. Effects of human T-cell leukemia virus type 1 (HTLV-1) p13 on mitochondrial K+ permeability: A new member of the viroporin family?. FEBS Lett. 2010, 584:2070-2075.
71. Smith K.A., Jacobson E.L., Emert R., Giordano M., Kovacs E., Mumneh N., Pilaro F., Sohn T., Warren D. Restoration of immunity with interleukin-2 therapy. AIDS Read. 1999, 9:563-572.
72. Sonoda S., Yashiki S., Takahashi K., Arima N., Daitoku Y., Matsumoto M., Matsumoto T., Tara M., Shinmyozu K., Sato K. Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives. Int. J. Cancer 1987, 40:629-634.
73. Sowinski S., Jolly C., Berninghausen O., Purbhoo M.A., Chauveau A., Kohler K., Oddos S., Eissmann P., Brodsky F.M., Hopkins C., Onfelt B., Sattentau Q., Davis D.M. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat. Cell Biol. 2008, 10:211-219.
74. Takatsuki K. Discovery of adult T-cell leukemia. Retrovirology 2005, 2:16.
75. Taner S.B., Onfelt B., Pirinen N.J., McCann F.E., Magee A.I., Davis D.M. Control of immune responses by trafficking cell surface proteins, vesicles and lipid rafts to and from the immunological synapse. Traffic 2004, 5:651-661.
76. Taylor J.M., Brown M., Nejmeddine M., Kim K.J., Ratner L., Lairmore M., Nicot C. Novel role for interleukin-2 receptor-Jak signaling in retrovirus transmission. J. Virol. 2009, 83:11467-11476.
77. Toei M., Saum R., Forgac M. Regulation and isoform function of the V-ATPases. Biochemistry 2010, 49:4715-4723.
78. Traina-Dorge V.L., Martin L.N., Lorino R., Winsor E.L., Beilke M.A. Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate. J. Infect. Dis. 2007, 195:562-571.
79. I protein greatly influences its stability. J. Virol. 1999, 73:6460-6467.
80. Uno H., Matsuoka H., Suzuki M., Tsuda K., Tsubouchi H. Altered expression of class I HLA antigen on peripheral mononuclear cells in patients with adult T-cell leukemia: inverse relationship with natural killer susceptibility. Cancer Epidemiol. Biomarkers Prev. 1995, 4:367-372.
81. Valeri, V., Hryniewicz, A., Andresen, V., Jones, K.S., Fenizia, C., Bialuk, I., Chung, H.K., Fukumoto, R., Parks, R.W., Ferrari, M.G., Nicot, C., Cecchinato, V., Ruscetti, F., Franchini, G., in press. Requirement of the human T-cell leukemia virus p12 and p30 genes for infectivity of human dendritic cells and macaques but not rabbits. Blood.
82. Van Prooyen, N., Gold, H., Andresen, V., Schwartz, O., Jones, K., Rucetti, F., Lockett, S., Prabhakar, G., Venzon, D., Franchini, G., submitted for publication. The HTLV-1 p8 protein increases cellular conduits and virus transmission.
83. Varshavsky A. The N-end rule: functions, mysteries, uses. Proc. Natl. Acad. Sci. USA 1996, 93:12142-12149.
84. Vernant J.C., Buisson G., Magdeleine J., De T.J., Jouannelle A., Neisson-Vernant C., Monplaisir N. T-lymphocyte alveolitis, tropical spastic paresis, and Sjogren syndrome. Lancet 1988, 1:177.
85. Watkins S.C., Salter R.D. Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 2005, 23:309-318.
86. Wu A.J., Fox P.C. Sjogren's syndrome. Semin. Dermatol. 1994, 13:138-143.
87. Wulfing C., Davis M.M. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 1998, 282:2266-2269.
88. Xu X., Kang S.H., Heidenrich O., Okerholm M., O'Shea J.J., Nerenberg M.I. Constitutive activation of different Jak tyrosine kinases in human T-cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J. Clin. Invest. 1995, 96:1548-1555.
89. Yarchoan R., Guo H.G., Reitz M., Maluish A., Mitsuya H., Broder S. Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I. J. Clin. Invest 1986, 77:1466-1473.
90. Zhu J., McKeon F. Nucleocytoplasmic shuttling and the control of NF-AT signaling. Cell Mol. Life Sci. 2000, 57:411-420.